The Union Health Ministry on Tuesday announced that phase III trials of the Oxford vaccine will begin this week in India.
It is likely that the Oxford University vaccine candidate — Covishield — will be the first one to move into production in India, sources have indicated to India Today TV.
The Oxford vaccine will begin phase III trials at 20 centres in India predominantly in Pune and Mumbai in Maharashtra and Ahmedabad in Gujarat. In this phase, the vaccine will be administered to 1,600 people.
“Some 20 different sites and hospitals across the country have been chosen, covering five different regions that are Covid-19 hotspots. We seek to conduct trials across 11-12 hospitals in partnership with ICMR,” said a spokesperson of the Serum Institute, the Indian production partner of the Oxford vaccine.
I run this site in my spare time and thoroughly enjoy giving you all positive news! If you’ve enjoyed the site we’d love for you to help me share the good news far and wide, share us on Reddit, your Facebook or your Twitter and spread a little positivity around.